title: Effect of caffeine treatment on plasma renin activity and angiotensin I concentrations in rats on a low sodium diet.
abstract: Animals treated acutely with an adenosine receptor antagonist have elevated plasma renin activity. This observation suggests that endogenous adenosine plays a physiologically significant role in restraining renin release. However, it is unclear whether chronic blockade of adenosine receptors would cause a rise of renin activity since tolerance to adenosine blockade is known to develop quickly. An earlier study partially addressed this question by showing that chronic blockade of adenosine receptors with caffeine exacerbated both the rise of plasma renin activity and the decline of renal function in 2-kidney-1-clip (2K1C) renovascular hypertensive rats. However, that study did not determine whether the difference in renin activity occurred solely as a secondary result of the difference in renal function. The purpose of this study was to reexamine the effect of chronic caffeine consumption on plasma renin activity and angiotensin I levels in animals in another high-renin model, i.e., the low sodium diet. The low sodium diet is devoid of the potential confounding effect of deteriorating renal function associated with the 2K1C renovascular hypertension model. In this study, animals received normal rat chow and drank either 0.1% caffeine water or vehicle for ten days. After ten days, all rats were switched to a low sodium diet for three weeks. Plasma renin activity and plasma angiotensin I levels were measured before, and at 1 and 3 weeks after initiating the low sodium diet. The results of this study show that chronic blockade of adenosine receptors with 0.1% caffeine water increases plasma renin activity and angiotensin I concentration before and throughout the three weeks when animals were on the low sodium diet. The results of this study suggest that the inhibitory role of adenosine on renin release is a general physiological process, rather than a special situation applicable only to the 2K1C model.
authors.affiliation: Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, R.O.C.
authors.forename: C J
authors.initials: CJ
authors.lastname: Tseng
authors.forename: C J
authors.initials: CJ
authors.lastname: Kuan
authors.forename: H
authors.initials: H
authors.lastname: Chu
authors.forename: C S
authors.initials: CS
authors.lastname: Tung
mesh_terms: D000803:Angiotensin I / Q000097:blood*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology*; D004039:Diet, Sodium-Restricted; D008297:Male; D008954:Models, Biological; D058914:Purinergic Antagonists; D051381:Rats; D017207:Rats, Sprague-Dawley; D012083:Renin / Q000097:blood*
chemical_list: D058914:Purinergic Antagonists; D002110:Caffeine; D000803:Angiotensin I; D012083:Renin